We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.39B
1-Year Est. Return 1.06%
This Fund
S&P 500
This Quarter Est. Return
+0.16%
1 Year Est. Return
-1.06%
3 Year Est. Return
+72.63%
5 Year Est. Return
+112.03%
10 Year Est. Return
+415.67%
AUM
$3.05B
AUM Growth
-$101M
Cap. Flow
-$84.8M
Cap. Flow %
-2.78%
Top 10 Hldgs %
61.06%
Holding
433
New
7
Increased
252
Reduced
12
Closed
4

Top Buys

Rank Stock Value
1
COHR icon
Coherent
COHR
+$21.9M
2
ZY
Zymergen Inc. Common Stock
ZY
+$21.5M
3
DIS icon
Walt Disney
DIS
+$14.9M
4
MMP
Magellan Midstream Partners, L.P.
MMP
+$3.4M
5
AMZN icon
Amazon
AMZN
+$2.07M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$116M
2
PYPL icon
PayPal
PYPL
+$52.7M
3
MDB icon
MongoDB
MDB
+$18.9M
4
BABA icon
Alibaba
BABA
+$11.6M
5
QTS
QTS REALTY TRUST, INC.
QTS
+$150K

Sector Composition

Rank Sector Weight
1 Healthcare 43.37%
2 Technology 10.04%
3 Communication Services 9.32%
4 Consumer Discretionary 7.6%
5 Utilities 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESPR
401
DELISTED
Esperion Therapeutics
ESPR
$14K ﹤0.01%
1,121
– –
KDP icon
402
Keurig Dr Pepper
KDP
$43B
$13K ﹤0.01%
371
+2
+0.5% +$70
LAB icon
403
Standard BioTools
LAB
$351M
$13K ﹤0.01%
1,975
– –
DELL icon
404
Dell
DELL
$262B
$12K ﹤0.01%
235
– –
OTIC
405
DELISTED
Otonomy, Inc.
OTIC
$12K ﹤0.01%
6,442
– –
SGMO
406
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$11K ﹤0.01%
1,273
– –
PINS icon
407
Pinterest
PINS
$13.7B
$10K ﹤0.01%
200
-200
-50% -$12.3K
PRTK
408
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$10K ﹤0.01%
2,159
– –
EWJ icon
409
iShares MSCI Japan ETF
EWJ
$22.1B
$9K ﹤0.01%
124
– –
FLXN
410
DELISTED
Flexion Therapeutics, Inc.
FLXN
$9K ﹤0.01%
1,406
– –
KRRO icon
411
Korro Bio
KRRO
$151M
$8K ﹤0.01%
22
– –
ZBH icon
412
Zimmer Biomet
ZBH
$18.4B
$7K ﹤0.01%
50
– –
JNCE
413
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$7K ﹤0.01%
1,009
– –
HPQ icon
414
HP
HPQ
$24.6B
$5K ﹤0.01%
169
+1
+0.6% +$29
ETTX
415
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$5K ﹤0.01%
1,448
– –
CTMX icon
416
CytomX Therapeutics
CTMX
$714M
$4K ﹤0.01%
712
– –
CNDT icon
417
Conduent
CNDT
$245M
$3K ﹤0.01%
530
– –
OIH icon
418
VanEck Oil Services ETF
OIH
$2.01B
$3K ﹤0.01%
16
– –
OXY.WS icon
419
Occidental Petroleum Corp Warrants
OXY.WS
$32B
$3K ﹤0.01%
216
– –
TTOO
420
DELISTED
T2 Biosystems, Inc
TTOO
$3K ﹤0.01%
1
– –
HPE icon
421
Hewlett Packard
HPE
$62.4B
$2K ﹤0.01%
164
+1
+0.6% +$14
WAB icon
422
Wabtec
WAB
$49.4B
$2K ﹤0.01%
21
– –
JXN icon
423
Jackson Financial
JXN
$8.5B
$1K ﹤0.01%
+53
New +$1.44K
MKC icon
424
McCormick & Company Non-Voting
MKC
$13.7B
$1K ﹤0.01%
12
– –
NBRV
425
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$1K ﹤0.01%
40
– –
14 15 16
17
18

Similar funds

BCM
Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $3.37B AUM
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return

Bollard Group's Q3 2021 Portfolio in Review

As of Q3 2021, Bollard Group held 433 positions worth $3.05B, down 3.2% from $3.15B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 2.5%. Bollard Group opened 7 new positions and exited 4, leaving the 433-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 45% a quarter earlier, followed by Technology and Communication Services.

  • Bollard Group's largest Q3 2021 buy was DraftKings: 26,591 shares worth $1.28M.
  • Bollard Group added most to Coherent in Q3 2021, an estimated $21.9M increase.
  • Bollard Group's biggest Q3 2021 reduction was Boston Scientific, cutting an estimated $116M.
  • Bollard Group fully exited QTS REALTY TRUST, INC. in Q3 2021, selling an estimated $150K.
  • Bollard Group's ten largest holdings make up 61% of its $3.05B portfolio in Q3 2021.
  • Bollard Group opened 7 new positions and closed 4 in Q3 2021.
  • Bollard Group's portfolio value fell 3.2% quarter-over-quarter to $3.05B.

Based on Bollard Group's 13F filing for Q3 2021, filed 12 Nov 2021.